Coronavirus Update: Pfizer/BioNTech Vaccine Effective Against Omicron
AstraZeneca Antibody Cocktail Gets EUA For PrEP
Also, AstraZeneca scores an emergency use authorization from the FDA for its COVID-19 PrEP antibody Evusheld, while Merck files for Japanese approval of molnupiravir.